| Pharmacokinetics of Benapenem in Subjects With Renal Impairment (NCT04476407) | Sihuan Pharmaceutical Holdings Group Ltd. | 2019-06-15 |
| Comparison of Pharmacokinetic (PK) and Pharmacodynamic(PD) of Biocon Insulin 70/30 and Humulin® 70/30 (NCT04022291) | Biocon Limited | 2019-06-15 |
| Deep Brain Stimulation for Treatment Resistant Depression (NCT04009928) | Sunnybrook Health Sciences Centre | 2019-06-15 |
| Comparision of Pharmacokinetic and Pharmacodynamic of Biocon Insulin N and Humulin® N (NCT04022304) | Biocon Limited | 2019-06-15 |
| Ivabradine for Rate Control in Permanent Atrial Fibrillation (NCT03987204) | Yale University | 2019-06-15 |
| Thermal Ablation Followed by Immunotherapy for HCC (NCT03864211) | Xiangya Hospital of Central South University | 2019-06-15 |
| A Clinical Drug-Drug Interaction (DDI) Study With Omaveloxolone (NCT04008186) | Biogen | 2019-06-14 |
| Encorafenib, Cetuximab, and Nivolumab in Treating Patients With Microsatellite Stable, BRAFV600E Mutated Unresectable or Metastatic Colorectal Cancer (NCT04017650) | M.D. Anderson Cancer Center | 2019-06-14 |
| Novel PET Radioligand as an Inflammatory Biomarker in Musculoskeletal Conditions (NCT03912428) | National Institute of Mental Health (NIMH) | 2019-06-14 |
| The Effect of High Fat Diet on the Pharmacokinetics of AD16 Tablets in Healthy Chinese Adult Subjects (NCT05787041) | South China Center For Innovative Pharmaceuticals | 2019-06-14 |
| A Phase I Clinical Study on SHR6390 in Healthy Chinese Volunteers (NCT05354336) | The Affiliated Hospital of Qingdao University | 2019-06-13 |
| Study of Nanrilkefusp Alfa Alone and With Pembrolizumab in Adult Patients With Advanced/Metastatic Solid Tumors (NCT04234113) | SOTIO Biotech AG | 2019-06-13 |
| Effect of GSK3640254 on the Pharmacokinetics of a Combination Oral Contraceptive (NCT03984825) | ViiV Healthcare | 2019-06-13 |
| A Study of Oral LOXO-292 (Selpercatinib) in Pediatric Participants With Advanced Solid or Primary Central Nervous System (CNS) Tumors (NCT03899792) | Eli Lilly and Company | 2019-06-13 |
| T-cells Expressing an Anti-SLAMF7 CAR for Treating Multiple Myeloma (NCT03958656) | National Cancer Institute (NCI) | 2019-06-13 |
| Pharmacokinetics of Plasma Doravirine Once Daily Over 72 Hours Following Drug Intake Cessation in Healthy Volunteers (NCT03894124) | Chelsea and Westminster NHS Foundation Trust | 2019-06-12 |
| [18F]Fluciclovine in Post-treatment Glioblastoma ( Axumin ) (NCT03990285) | Ali Nabavizadeh | 2019-06-12 |
| A Study Evaluating the Safety, Pharmacokinetics and Efficacy of Ipatasertib Administered in Combination With Rucaparib in Participants With Advanced Breast, Ovarian Cancer, and Prostate Cancer. (NCT03840200) | Hoffmann-La Roche | 2019-06-12 |
| ET019003-T Cells in Relapsed/Refractory CD19+ B-Cell Leukemia and Lymphoma (NCT04014894) | Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | 2019-06-12 |
| Modified Virus VSV-IFNbetaTYRP1 in Treating Patients With Stage III-IV Melanoma (NCT03865212) | Mayo Clinic | 2019-06-12 |
| A Study to Find the Best Dose of BI 836880 Alone and in Combination With BI 754091 in Japanese Patients With Different Types of Advanced Cancer (NCT03972150) | Boehringer Ingelheim | 2019-06-12 |
| A Study of LY3502970 in Healthy Participants (NCT03929744) | Eli Lilly and Company | 2019-06-12 |
| Exercise Treatment With Standard Therapy for Metastatic Breast Cancer (NCT03988595) | Memorial Sloan Kettering Cancer Center | 2019-06-12 |
| Study of Nalbuphine ER in Participants With Hepatic Impairment (NCT04020016) | Trevi Therapeutics | 2019-06-12 |
| CCR5-modified CD4+ T Cells for HIV Infection (NCT03666871) | University of Cincinnati | 2019-06-12 |
| The Safety, Tolerability, and Initial Efficacy of HX009 in Patients With Advanced Malignancies (NCT04097769) | Waterstone Hanxbio Pty Ltd | 2019-06-12 |
| Evaluate Taste and Relative Bioavailability of Two Microsphere Formulations of Crizotinib in Healthy Participants (NCT03978143) | Pfizer | 2019-06-12 |
| SX-682 Treatment in Subjects With Metastatic Melanoma Concurrently Treated With Pembrolizumab (NCT03161431) | Syntrix Biosystems, Inc. | 2019-06-12 |
| Study of TQB2450 Combined With Anlotinib in Patients With Advanced Non-small Cell Lung Cancer（NSCLC） (NCT03910127) | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 2019-06-11 |
| A Comparative Pharmacokinetic and Pharmacodynamic Study of Sildenafil in Adult Smokers and Non Smokers (NCT04100759) | Ain Shams University | 2019-06-11 |
| Study of Tisagenlecleucel in Combination With Ibrutinib in r/r Diffuse Large B-cell Lymphoma Patients (NCT03876028) | Novartis Pharmaceuticals | 2019-06-11 |
| Olaparib in Combination With Vorinostat in Patients With Relapsed/Refractory and/or Metastatic Breast Cancer (NCT03742245) | The Methodist Hospital Research Institute | 2019-06-11 |
| Study of TQB2450 Combined With Anlotinib in Subjects With Advanced Acral Malignant Melanoma (NCT03991975) | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 2019-06-11 |
| Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of EYP001a in Healthy Volunteers and Nonalcoholic Steatohepatitis Patients (NCT03976687) | Enyo Pharma | 2019-06-11 |
| A Study to Evaluate the Pharmacokinetics, Safety and Tolerability of ABBV-157 in Healthy Volunteers and in Participants With Chronic Plaque Psoriasis (NCT03922607) | AbbVie | 2019-06-11 |
| Single Ascending-dose Study to Evaluate Safety, Tolerability, and PK of MYMD1 in Healthy Male Adult Subjects (NCT04349761) | TNF Pharmaceuticals, Inc. | 2019-06-11 |
| Mass Balance Recovery, Pharmacokinetics and Metabolite Profile and Identification of [14C]AZD7594 (NCT04002427) | AstraZeneca | 2019-06-11 |
| Assessing Radio-hybrid Prostate Specific Membrane Antigen (rhPSMA-7.3) (18F) in Healthy Volunteers and Subjects With Prostate Cancer (NCT03995888) | Blue Earth Diagnostics | 2019-06-11 |
| Gene Therapy Clinical Study in Adult PKU (NCT03952156) | Homology Medicines, Inc | 2019-06-10 |
| Study to Assess the Food Effect on the Pharmacokinetics of Nifurtimox Tablets in Chronic Chagas' Patients - Dietary Habits Study (NCT03334838) | Bayer | 2019-06-10 |
| Nicotinic Receptor Genetic Variation and Alcohol Reward (NCT03294460) | National Institute on Alcohol Abuse and Alcoholism (NIAAA) | 2019-06-10 |
| Clinical Trial to Evaluate CT053 in Patients With Relapsed and/or Refractory Multiple Myeloma (LUMMICAR STUDY 1) (NCT03975907) | CARsgen Therapeutics Co., Ltd. | 2019-06-10 |
| Flublok or Fluzone With Advax-CpG55.2 or AF03 (NCT03945825) | National Institute of Allergy and Infectious Diseases (NIAID) | 2019-06-10 |
| Clinical Trial of Dose-tolerance, Pharmacokinetics and Iodine Uptake For rhTSH In Post-thyroidectomized Patients (NCT04137185) | Suzhou Zelgen Biopharmaceuticals Co.,Ltd | 2019-06-10 |
| Phase 1/2 Study of TP-0903 (an Inhibitor of AXL Kinase) in Patients With Previously Treated CLL (NCT03572634) | Sumitomo Pharma America, Inc. | 2019-06-10 |
| Clinical Pharmacology Study of Oral Edaravone in Healthy Adult Subjects (Food Effect Study) (NCT05342597) | Shionogi | 2019-06-10 |
| Avelumab With Radiotherapy in Patients With Leptomeningeal Disease (NCT03719768) | H. Lee Moffitt Cancer Center and Research Institute | 2019-06-10 |
| Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) of GSK2831781 After an Intravenous (IV) Dose in Healthy Japanese and Caucasian Subjects, and a Subcutaneous (SC) Dose in Healthy Caucasian Subjects (NCT03965533) | GlaxoSmithKline | 2019-06-10 |
| Phase IB & II Study of Ribociclib With Trastuzumab Plus Letrozole in Postmenopausal HR+, HER2+ Advanced Breast Cancer Patients (NCT03913234) | Yonsei University | 2019-06-10 |
| Gemcitabine Combined With Apatinib and Toripalimab in Recurrent or Metastatic Nasopharyngeal Carcinoma. (NCT04073784) | Sun Yat-sen University | 2019-06-08 |
| Alpelisib and Enzalutamide in Treating Patients With Androgen Receptor and PTEN Positive Metastatic Breast Cancer (NCT03207529) | M.D. Anderson Cancer Center | 2019-06-07 |
| A First-in-human Study to Investigate the Safety, Tolerability and Pharmacokinetics of MAS825 in Healthy Volunteers (NCT04665154) | Novartis Pharmaceuticals | 2019-06-07 |
| A Food-Effect Study of E7386 in Healthy Participants (NCT03996226) | Eisai Inc. | 2019-06-07 |
| Interleukin-15 (IL-5) in Combination With Avelumab (Bavencio) in Relapsed/Refractory Mature T-cell Malignancies (NCT03905135) | National Cancer Institute (NCI) | 2019-06-07 |
| A Study in Healthy Men to Test the Effects of Different Doses of BI 1467335 on MAO-B Activity in the Brain. (NCT03927209) | Boehringer Ingelheim | 2019-06-06 |
| Phase I/II Trial of CPX-351 + Palbociclib in Patients With Acute Myeloid Leukemia (NCT03844997) | Sudipto Mukherjee, MD, PhD, MPH | 2019-06-06 |
| Radiotherapy and Durvalumab/Durvalumab Combo (Tremelimumab/Olaparid) for Small Cell Lung Cancer (NCT03923270) | H. Lee Moffitt Cancer Center and Research Institute | 2019-06-06 |
| A Window of Opportunity Study to Investigate Mechanisms of Actions of Novel Therapeutic Agents in Patients With Resectable Solid Tumor Malignancies (NCT03471286) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2019-06-06 |
| A Study of Three Different Doses of VAC52416 (ExPEC10V) in Adults Aged 60 to 85 Years in Stable Health (NCT03819049) | Janssen Research & Development, LLC | 2019-06-06 |
| A Performance and Bioavailability Study of Entrectinib in Healthy Volunteers. (NCT03961100) | Genentech, Inc. | 2019-06-06 |
| Compare Pharmacokinetic, Safety, Tolerability and Immunogenicity of HLX12 and Ramucirumab in Healthy Male Adult Subjects (NCT03863587) | Shanghai Henlius Biotech | 2019-06-06 |
| Niraparib in Combination With Osimertinib in EGFR-Mutated Advanced Lung Cancer (NCT03891615) | Massachusetts General Hospital | 2019-06-06 |
| Low-dose IL-2 to the Kinetics of Regulatory T-cell in Healthy Volunteers (NCT03837093) | Assistance Publique - Hôpitaux de Paris | 2019-06-06 |
| A Trial to Assess Safety and Efficacy of ADO09 Versus Insulin Aspart in Subjects With Type 1 Diabetes Mellitus (NCT03981627) | Adocia | 2019-06-06 |
| Phase IB Metformin, Digoxin, Simvastatin in Solid Tumors (NCT03889795) | Danae Hamouda, MD | 2019-06-05 |
| A Study to Look at How Safe NNC0268-0965 is in Healthy People and People With Type 1 Diabetes (NCT03965013) | Novo Nordisk A/S | 2019-06-05 |
| A Study of Abemaciclib in Combination With Sunitinib in Metastatic Renal Cell Carcinoma (NCT03905889) | Brown University | 2019-06-05 |
| Vaccination Efficacy With Metformin in Older Adults (NCT03996538) | UConn Health | 2019-06-05 |
| A Study to Compare PK, PD and Safety of the AD-206 and Esomeprazole (NCT03980756) | Addpharma Inc. | 2019-06-05 |
| Safety, Tolerance and Pharmacokinetics Study of Compound Edaravone Injection (NCT04219865) | Nanjing Yoko Biomedical Co., Ltd. | 2019-06-05 |
| Safety Study of 15-Valent Pneumococcal Conjugate Vaccine in Healthy Volunteers Aged Above 2 Months (NCT04108845) | Beijing Zhifei Lvzhu Biopharmaceutical Co., Ltd | 2019-06-05 |
| Study to Investigate Safety, Tolerability, Pharmacokinetics, and Drug-drug Interaction of Multiple Oral Doses of BAY1830839 in Healthy Male Participants (NCT03965728) | Bayer | 2019-06-05 |
| Safety of Intra-Articular Sc-rAAV2.5IL-1Ra in Subjects With Moderate Knee OA (NCT02790723) | Mayo Clinic | 2019-06-05 |
| The Effect of Glucagon on Rates of Hepatic Mitochondrial Oxidation in Man Assessed by PINTA (NCT03965130) | Yale University | 2019-06-05 |
| Lopinavir/r/ Lamivudine/ Abacavir as an Easy to Use Paediatric Formulation (NCT03836833) | Drugs for Neglected Diseases | 2019-06-04 |
| Intraperitoneal Infusion of ex Vivo-cultured Allogeneic NK Cells in Recurrent Ovarian Carcinoma Patients (NCT03539406) | Radboud University Medical Center | 2019-06-04 |
| Pharmacokinetics and Bioequivalence of Rivaroxaban Tablet in Healthy Chinese Volunteers (NCT04424381) | The Affiliated Hospital of Qingdao University | 2019-06-04 |
| A Trial of SHR-1210 (an Anti-PD-1 Inhibitor) in Combination With Apatinib and Fluzoparib in Patients With TNBC (NCT03945604) | Jiangsu HengRui Medicine Co., Ltd. | 2019-06-04 |
| A Phase 1/2 Clinical Trial of a GamLPV, a Live Intranasal Bordetella Pertussis Vaccine (NCT04036526) | Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation | 2019-06-04 |
| Temporary Inactivation of Strong Muscle Sensation to Improve Rehabilitation Interventions in SCI (NCT05589402) | University of Texas Rio Grande Valley | 2019-06-04 |
| Safety Study of BLS-M22 in Healthy Volunteers (NCT03789734) | BioLeaders Corporation | 2019-06-04 |
| Clinical Study to Evaluate the Pharmacokinetic Profiles and Safety of CKD-348 in Healthy Volunteers (NCT04272502) | Chong Kun Dang Pharmaceutical | 2019-06-04 |
| Study of Intratumoral Ipilimumab and TLR4 Agonist GLA-SE in Combination With Systemic Nivolumab and Chemotherapy (NCT03982121) | Gustave Roussy, Cancer Campus, Grand Paris | 2019-06-04 |
| Impact of Steady State Cobicistat and Darunavir/Cobicistat on the Pharmacokinetics and Pharmacodynamics of Oral Anticoagulants (Rivaroxaban, Apixaban) in Health Volunteers (NCT03864406) | National Institutes of Health Clinical Center (CC) | 2019-06-04 |
| The MOCA I Study - Microvascular Obstruction with CoFI™ System Assessment (NCT03654573) | CorFlow Therapeutics AG | 2019-06-04 |
| A Study to Evaluate the Safety,PK and PD of APG-2575 in Patients With Hematologic Malignancies (NCT03913949) | Ascentage Pharma Group Inc. | 2019-06-03 |
| The Effect of N-acetylcysteine on Oxidative Stress Status and Iron Overload in Thalassemia Major (NCT04260516) | Beni-Suef University | 2019-06-03 |
| A Study to Evaluate the Pharmacokinetics and Safety of HCP1704 in Healthy Subjects (NCT04081857) | Hanmi Pharmaceutical Company Limited | 2019-06-03 |
| First-in-Human Study With Single and Multiple Doses of TS-161 in Healthy Participants (NCT03919409) | Taisho Pharmaceutical R&D Inc. | 2019-06-03 |
| Bioequivalence (BE) Study Comparing Fluconazole 150mg Capsule Manufactured in China and in France (NCT03621072) | Pfizer | 2019-06-03 |
| Study of TQB2450 Combined With Anlotinib in the Treatment of Mutation Positive Lung Cancer (NCT03983928) | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 2019-06-03 |
| Bioequivalence Study of Two Roxithromycin Tablets in Healthy Subjects (NCT06798051) | The Affiliated Hospital Of Guizhou Medical University | 2019-06-03 |
| A Phase I Study Evaluating the Safety, Tolerability, PK and PD in Healthy Chinese Volunteers (NCT03971916) | Harbour BioMed (Guangzhou) Co. Ltd. | 2019-06-03 |
| Study of Dalutrafusp Alfa (Formerly GS-1423) in Participants With Advanced Solid Tumors (NCT03954704) | Gilead Sciences | 2019-06-03 |
| Study to Assess the Safety, Tolerability, Pharmacokinetic, and Pharmacodynamic Effects of a Single Dose of REGN5713-5714-5715 in Healthy Adult Participants (NCT03969849) | Regeneron Pharmaceuticals | 2019-06-03 |
| Study of TBX-3400 in Patients With Stage III and IV Melanoma Resistant or Refractory to Immune Checkpoint Inhibitors (NCT03385486) | Taiga Biotechnologies, Inc. | 2019-06-02 |
| PD-1 Inhibitors Consolidation in Extensive-stage Small Cell Lung Cancer (NCT03971214) | Chinese Academy of Medical Sciences | 2019-06-01 |
| Assessment of Trace Elements, Systemic Inflammation and Electrolytes (NCT05718453) | Egymedicalpedia | 2019-06-01 |
| Clinical Study of NK Cells in the Treatment of Severe Endometriosis (NCT03948828) | Shenzhen People's Hospital | 2019-06-01 |
| Study of Autologous Cytotoxic T Lymphocyte Immunotherapy Combination With PD-1 Inhibitor in the Advanced NSCLC (NCT04193098) | Tianjin Medical University Cancer Institute and Hospital | 2019-06-01 |